No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs567210157 |
chr21:47314900-47314901 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs534642376 |
chr21:47314918-47314919 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs191939109 |
chr21:47314932-47314933 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs368862142 |
chr21:47314936-47314937 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs144355569 |
chr21:47314946-47314947 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs116270017 |
chr21:47314953-47314954 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs183992243 |
chr21:47314954-47314955 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs530170557 |
chr21:47314955-47314956 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs570036224 |
chr21:47314991-47314992 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs537457950 |
chr21:47314992-47314993 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs555832331 |
chr21:47315024-47315025 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs8130202 |
chr21:47315045-47315046 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
13 |
rs189118820 |
chr21:47315080-47315081 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs553492622 |
chr21:47315085-47315086 |
Weak transcription Enhancers Bivalent Enhancer
|
TF binding regionChromatin interactive region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs181667132 |
chr21:47315111-47315112 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs57179897 |
chr21:47315186-47315187 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
17 |
rs545060648 |
chr21:47315187-47315188 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs73907906 |
chr21:47315205-47315206 |
Weak transcription Bivalent Enhancer Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs187298069 |
chr21:47315219-47315220 |
Weak transcription Bivalent Enhancer Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs56303116 |
chr21:47315229-47315230 |
Weak transcription Bivalent Enhancer Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs374496689 |
chr21:47315237-47315238 |
Weak transcription Bivalent Enhancer Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs528379923 |
chr21:47315246-47315247 |
Weak transcription Bivalent Enhancer Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs546585525 |
chr21:47315265-47315266 |
Weak transcription Bivalent Enhancer Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs571372366 |
chr21:47315272-47315273 |
Weak transcription Bivalent Enhancer Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs532226400 |
chr21:47315318-47315319 |
Weak transcription Bivalent Enhancer Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs551861687 |
chr21:47315329-47315330 |
Weak transcription Bivalent Enhancer Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs190738795 |
chr21:47315333-47315334 |
Weak transcription Bivalent Enhancer Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs537570440 |
chr21:47315340-47315341 |
Weak transcription Bivalent Enhancer Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs547061034 |
chr21:47315362-47315363 |
Weak transcription Bivalent Enhancer Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs182024816 |
chr21:47315377-47315378 |
Weak transcription Bivalent Enhancer Enhancers Genic enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs141396368 |
chr21:47315414-47315415 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs550311455 |
chr21:47315415-47315416 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs9979000 |
chr21:47315422-47315423 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs553414250 |
chr21:47315435-47315436 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs114387718 |
chr21:47315439-47315440 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs7277666 |
chr21:47315454-47315455 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
37 |
rs367784851 |
chr21:47315505-47315506 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs532510980 |
chr21:47315521-47315522 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs35207744 |
chr21:47315542-47315543 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs114939234 |
chr21:47315545-47315546 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs7278917 |
chr21:47315552-47315553 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs182535427 |
chr21:47315569-47315570 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs552705817 |
chr21:47315626-47315627 |
Weak transcription Genic enhancers Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs143452972 |
chr21:47315662-47315663 |
Weak transcription Genic enhancers Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs540491567 |
chr21:47315670-47315671 |
Weak transcription Genic enhancers Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs565045441 |
chr21:47315704-47315705 |
Weak transcription Genic enhancers Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs9975891 |
chr21:47315709-47315710 |
Weak transcription Genic enhancers Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs570036204 |
chr21:47315711-47315712 |
Weak transcription Genic enhancers Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs550772826 |
chr21:47315765-47315766 |
Weak transcription Genic enhancers Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs569119009 |
chr21:47315817-47315818 |
Weak transcription Genic enhancers Bivalent Enhancer Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|